(Q47728296)

5 February 2018

title

Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patients (English)

1 reference

5 February 2018

1 reference

10

1 reference

5 February 2018

Viviana P Lutzky

1

object named as

Viviana P Lutzky

1 reference

5 February 2018

author name string

Joanne E Davis

2

1 reference

5 February 2018

Pauline Crooks

3

1 reference

5 February 2018

Monika Corban

4

1 reference

5 February 2018

Mark C Smith

5

1 reference

5 February 2018

Michael Elliott

6

1 reference

5 February 2018

Leanne Morrison

7

1 reference

5 February 2018

Simone Cross

8

1 reference

5 February 2018

David Tscharke

9

1 reference

5 February 2018

William Coman

11

1 reference

5 February 2018

Mandvi Bharadwaj

12

1 reference

5 February 2018

Denis J Moss

13

1 reference

5 February 2018

publication date

26 May 2009

1 reference

5 February 2018

Immunology & Cell Biology

published in

1 reference

5 February 2018

volume

87

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

481-488

1 reference

5 February 2018

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Bystander apoptosis induced by CD8+ cytotoxic T cell (CTL) clones: implications for CTL lytic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Use of CD107-based cell sorting ex vivo to enrich subdominant CD8+ T cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

inferred from DOI database lookup

7 January 2021

based on heuristic

Cost-efficient quantification of enzyme-linked immunospot

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.25

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ICB.2009.25

1 reference

5 February 2018

1 reference

5 February 2018